Speakers

Kurt Gunter

Chief Medical Officer

Kuur Therapeutics

Sonny Hsiao

Founder & CEO

Acepodia

Stewart Abbot

CSO & COO

Adicet Bio

Sicco Popma

CEO, President & Founder

IO Biosciences

Matthias Von Herrath

VP & Senior Medical Officer, Global Chief Medical Officer

Novo Nordisk

Dario Gutierrez

VP, Discovery Research & Innovation

TCR2 Therapeutics

Rob Igarashi

VP, Discovery & Pre-clinical Development

Kiadis Pharma

Monalisa Mukherjea

Associate Director, Autologous and Allogeneic CAR-T Process Development & Manufacturing

Janssen, J&J

Tom Van Blarcom

Senior Director & Head of Protein Engineering

Allogene

Joanna Brewer

SVP, Allogeneic Research

Adaptimmune

Mark Exley

VP, Cellular Immunology

AgenTus

Mike Lehmicke

Director, Science & Industry Affairs

Alliance for Regenerative Medicine

Barbra Sasu

CSO

Allogene

Joe Newell

COO

Atara Biotherapeutics

Pascal Touchon

President & CEO

Atara Biotherapeutics

Debra Webster

Senior Director, Regulatory Affairs

BlueRock Therapeutics

Anne-Sophie Lebrun

Production & Optimisation Manager

Bone Therapeutics

Nathan Yee

Associate Director, CMC Product Strategy, Allogeneic Cell Therapy

Bristol Myers Squibb

Emilie Gauthy

R&D Manager, CMC & Process Development

Celyad Oncology

Peggy Sotiropoulou

Head of Research & Development

Celyad Oncology

Zhiqiang Wang

Assistant Research Professor

City of Hope

Tony Ho

EVP, Head of Research & Development

CRISPR Therapeutics

Olive Sturtevant

Senior Administrative Director of Connell & O’Reilly Families, Cell Manipulation Core Facility

Dana Farber Cancer Institute

Greg Fiore

CEO

Exacis Biotherapeutics

Karl-Johan Malmberg

Professor

Karolinska Institute

Brian Culley

CEO

Lineage Cell Therapeutics

Elizabeth Akam

Lecturer, Biochemistry

Loughborough University

Lior Raviv

VP, Development & Operations

Pluristem

Sumiti Jain

Director, Immuno- Oncology, Cell Therapy

Poseida Therapeutics

Christina Coughlin

CMO

Rubius Therapeutics

Dan Kaufman

Professor & Director, Cell Therapy Program

UCSD

Marica Grskovic

VP, Cell Transplant Therapy

Care Dx

Ian Taylor

Chief Business Officer

Solentim

André Choulika

CEO

Cellectis

Evan Zynda

Scientist, Cell Biology

Thermo Fisher Scientific

Dominic Clarke

Director, Global Cell Therapy Strategy & Innovation

HemaCare

Brittni Peterson

Product Manager, Cell and Gene Therapy

Bio-Techne

Lan Cao

Head, Platform & Product Development, Cell Therapy

Takeda Pharmaceutical

David Lebwohl

CMO

Intellia Therapeutics

Elsa Abranches

Acting Head, Division of Advanced Therapies & Director, UK Stem Cell Bank

National Institute for Biological Standards and Control

Christopher Kloss

Assistant Principal Scientist, Cell & Gene Therapy

Merck & Co

Zhimei Du

Cell Product & Engineering, Bioprocess & Clinical Manufacturing

Merck & Co

Arie Van Oorschot

Production Manager

Glycostem Therapeutics

Mark Johnson

Clinical Translational Scientist

Precision Biosciences

Rashmi Kshirsagar

VP, Technical Development

Rubius Therapeutics

John Piccone

Principal, Global Lead- Biomedical Research

ZS

Preeti Premraj

Scientific Solutions Lead, Biomedical Research

ZS

Emilie Gateau

Platform Development Manager

Exothera

Robert Margolin

Vice President of Corporate Development

Akron Biotech

Joy Aho

Senior Product Manager

Be The Match BioTherapies

EVENT GUIDE